Arkolith/Insider Trading/IMPL/Form 4

Leaman John Harold

Chief Fin. & Business OfficerIMPEL PHARMACEUTICALS INC (IMPL) · full profile →Form 4 · filed Jan 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2022Option exercise(M)11K—$011K
Dec 31, 2022Tax withholding(F)4K$3.75$14K7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2022Option exercise(M)11K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-001365) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML